Separate names with a comma.
CBS ran the report. Not Frequency Therapeutics.
Sounds like the hyperacusis I had for a long time. But I think the better term is "recruitment." Basically what's happening is you've got some...
It may or may not need a Phase 3. Depends on if Phase 2b meets endpoints, and FDA says a Phase 3 is needed. By now, almost 300 patients have...
The FDA is specific on approving a drug to be sold in the US: 1. Favorable safety profile (low risk, or well-defined risks). 2. Specific target...
A quack.
This honestly seems about right in terms of sale price. Consider what an asset pricing sheet for the patents / know-how would look like. They have...
Yes. Over time the occasional gathering will be fine.
They received a grant from the DoD prior to the FX-322 Phase 1/2.
Today is my 4th anniversary of acquiring intrusive T and H. To those of you that are new and still struggling to cope... it gets easier.
It depends, but until a few million people have sampled the drug in their ears, one can only speculate. I suspect genetic conditions play a factor...
It should be noted that the drug cannot provide a permanent gain, either. It has demonstrated that to some extent it is causing the regeneration...
He wouldn't have been allowed into the trial (assuming Phase 1/2 based on the description in the video) unless he had demonstrated that his...
I wonder if he was patient 937 from the Phase 1/2?
If the OTO-413 trial demonstrated more convincing positive outcomes, they would certainly not have gone down the same path. They would have...
It's unknown. So just saying "multiple doses didn't work" is misleading. And FREQ hasn't bothered investigating timing of the dosing, or any other...
